BIRMINGHAM, Ala. – Astrazeneca failed to warn that its Nexium, for gastroesophageal reflux, can cause debilitating spinal injuries, a patient claims in Jefferson County Court.
My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
BIRMINGHAM, Ala. – Astrazeneca failed to warn that its Nexium, for gastroesophageal reflux, can cause debilitating spinal injuries, a patient claims in Jefferson County Court.
Subscribe now to keep reading and get access to the full archive.